GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Xcell Therapeutics Inc (XKRX:373110) » Definitions » Retained Earnings

Xcell Therapeutics (XKRX:373110) Retained Earnings : ₩-53,270 Mil (As of Sep. 2024)


View and export this data going back to 2024. Start your Free Trial

What is Xcell Therapeutics Retained Earnings?

Retained earnings is the accumulated portion of net income that is not distributed to shareholders. Xcell Therapeutics's retained earnings for the quarter that ended in Sep. 2024 was ₩-53,270 Mil.

Xcell Therapeutics's quarterly retained earnings declined from Mar. 2024 (₩-48,440 Mil) to Jun. 2024 (₩-50,583 Mil) and declined from Jun. 2024 (₩-50,583 Mil) to Sep. 2024 (₩-53,270 Mil).

Xcell Therapeutics's annual retained earnings declined from Dec. 2021 (₩-28,492 Mil) to Dec. 2022 (₩-36,791 Mil) and declined from Dec. 2022 (₩-36,791 Mil) to Dec. 2023 (₩-46,174 Mil).


Xcell Therapeutics Retained Earnings Historical Data

The historical data trend for Xcell Therapeutics's Retained Earnings can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Xcell Therapeutics Retained Earnings Chart

Xcell Therapeutics Annual Data
Trend Dec19 Dec20 Dec21 Dec22 Dec23
Retained Earnings
-9,233.32 -19,368.10 -28,492.44 -36,790.55 -46,174.20

Xcell Therapeutics Quarterly Data
Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24
Retained Earnings Get a 7-Day Free Trial - -46,174.20 -48,440.18 -50,582.92 -53,270.37

Xcell Therapeutics Retained Earnings Calculation

Retained Earnings is the accumulated portion of net income that is not distributed to shareholders. Because the net income was not distributed to shareholders, shareholders' equity is increased by the same amount.

Of course, if a company loses, it is called retained losses, or accumulated losses.


Xcell Therapeutics  (XKRX:373110) Retained Earnings Explanation

Historically profitable companies sometimes have negative retained earnings. This is because they have cumulatively paid out more to shareholders than they reported in profits.

For example, in 2011, Microsoft had negative retained earnings. This does not mean the company lost more money than it made over the years. It just means it paid out more money than it earned.

If a company has negative retained earnings, investors should check the 10-year financial results. They should not assume that negative retained earnings prove a company has generally lost money in the past.

Of course, many companies with negative retained earnings have indeed lost money in the past.

Retained Earnings: Warren Buffett's Secret.

One of the most important indicators of durable competitive advantage. Net earnings can be paid out as dividends, used to buy back shares or retained for growth.

If the company loses more than it has accumulated, retained earnings is negative.

If a company isn't adding to its retained earnings, it isn't growing its net worth.

Rate of growth of retained earnings is good indicator whether it's benefiting from a competitive advantage.

Microsoft is negative because it chose to buyback stock and pay dividends.

The more earnings retained, the faster it grows and increases growth rate for future earnings.


Xcell Therapeutics Business Description

Comparable Companies
Traded in Other Exchanges
N/A
Address
333, Yeongdong-daero, Gangnam-gu, Seoul, KOR, 06188
Xcell Therapeutics Inc operates as a research company engaged in development of regenerative medicines. The company is developing proliferation media for various animal cell types.

Xcell Therapeutics Headlines

No Headlines